A young boy from England has become the first patient in the world to trial a groundbreaking device designed to control his severe epilepsy.
Oran Knowlson, who suffers from Lennox-Gastaut syndrome, underwent surgery in October at Great Ormond Street Hospital in London and has since shown considerable improvements.
Seizures Reduced by 80%
The neurostimulator, fitted in Oran’s skull, has reduced his daytime seizures by 80%, the family said.
His mother, Justine, told the BBC that the device has significantly improved his quality of life, making him happier and healthier.
Before the surgery, Justine recounted that Oran would fall, shake violently, lose consciousness, and sometimes stop breathing due to seizures.
How The Device Works?
The newly implanted device blocks the abnormal bursts of electrical activity that takes place in epileptic patients.
The surgeons screwed two electrodes that reached Oran’s thalamus and the ends connected to a neurostimulator placed on Oran’s skull for an efficient and smooth flow of neural signals.
